medigraphic.com
SPANISH

Revista Médica del Hospital General de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2001, Number S1

<< Back Next >>

Rev Med Hosp Gen Mex 2001; 64 (S1)

Celecoxib for treatment of inflammation and pain in Rheumatology

Irazoque PF
Full text How to cite this article

Language: Spanish
References: 16
Page: 16-19
PDF size: 63.11 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Klippel JH, ed. Non-Steroidal antiinflamatory drugs. Primer on Rheumatic Diseases. 11 ed. Atlanta: Ed Arthritis Foundation. 1997: 478-83.

  2. Martínez-Elizondo P, ed. Introducción a la Reumatología. 2 ed. México: Sociedad Mexicana de Reumatología 1997.

  3. Roig ED. Reumatología en la consulta diaria. 1 ed. Barcelona: Liga Panamericana contra el Reumatismo 1987.

  4. Moll JMH. Reumatología en la Práctica Clínica. México: CEA 1994.

  5. Emery P, Zeidler H, Kvien TK et al. Celecoxib versus diclofenac in long term management of rheumatoid arthritis: randomized double-blind comparison. Lancet 1999; 354: 2106-2111.

  6. Raymond N, Steven B et al. La ciclooxigenasa en el campo de la biología y los padecimientos. The FASEB Journal 1998; 12: 1063-1073.

  7. Cashman JN. The mechanism of action of NSAID in analgesia. Drugs 1996; 52: 13-23.

  8. Lane NE et al. Pain management in osteoarthritis, the role of COX-2 inhibitors. J Rheumatol 1997; 24: 20-24.

  9. Goldenberg MM. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin Ther 1999; 21: 1497-1513.

  10. Alarcón GA, Barreda AR. Celecoxib vs naproxeno, eficacia y tolerabilidad en osteoartrosis. Estudio multicéntrico comparativo, doble ciego, aleatorizado. Rev Mex Reumat 2000; 15: 95-105.

  11. Simon LS, Lanza FL, Lipsky PE et al. Preliminary study of the safety and efficacy of SC–58635, a novel cyclooxygenase 2 inhibitor. Arthritis Reum 1998; 41: 1591-1602.

  12. Zhao SZ, Hatoum HT et al. Efecto del celecoxib, un nuevo inhibidor específico de COX-2 sobre la calidad de vida relacionada con la salud de pacientes con osteoartrosis de rodilla. Arthritis Rheum 1997; 40 Suppl. 88.

  13. Silverstein FE, Faich G et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS Study: A randomized controlled trial. JAMA 2000; 284, 10.

  14. Malmstrom K, Daniels S, Kotey P et al. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors in postoperative dental pain: a randomized, placebo-and active comparator-controlled clinical trial. Clin Ther 1999; 21: 1653-63.

  15. Brugger AM, Richardson ET, Drupka DT et al. Comparison of celecoxib, hidrocodone-acetaminophen, and placebo for relief of post-surgical pain. 18th Am Pain Soc 1999 Oct 21.

  16. Delyth C, Karen L Goa. A review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000; 59 (4).




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Hosp Gen Mex. 2001;64